Development and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
The advancement of drug delivery systems has revolutionized the field of oncology by enabling targeted therapy for cancer treatment. This thesis focuses on the development and evaluation of novel drug delivery systems specifically designed for targeted cancer therapy. The primary objective is to enhance the efficacy of cancer treatment while minimizing systemic side effects through the targeted delivery of therapeutic agents to tumor sites. Chapter 1 provides the foundation for this research work, starting with an introduction to the significance of targeted drug delivery in cancer therapy. The background of the study highlights the current challenges in cancer treatment, emphasizing the need for innovative drug delivery systems. The problem statement identifies the gaps in existing therapies, and the objectives of the study outline the specific goals to be achieved. The limitations and scope of the study set the boundaries for the research, while the significance of the study underscores its potential impact. Finally, the structure of the thesis and definition of key terms establish the framework for the subsequent chapters. Chapter 2 presents a comprehensive literature review that examines previous studies and developments in targeted drug delivery systems for cancer therapy. The review covers various aspects such as nanotechnology, immunotherapy, and personalized medicine, providing insights into the latest advancements and challenges in the field. Chapter 3 details the research methodology employed in this study, including the selection of experimental models, materials, and techniques used for the development and evaluation of novel drug delivery systems. The chapter also discusses the experimental design, data collection methods, and statistical analysis procedures. In Chapter 4, the findings of the research are elaborated upon, highlighting the efficacy and specificity of the novel drug delivery systems in targeting cancer cells. The discussion delves into the mechanisms of action, bio-distribution, and therapeutic outcomes of the developed systems, comparing them with existing approaches. Finally, Chapter 5 presents the conclusion and summary of the thesis, summarizing the key findings, implications, and contributions of the research work. The conclusion also discusses the potential future directions and applications of the novel drug delivery systems in clinical practice. In conclusion, this thesis contributes to the field of oncology by introducing innovative drug delivery systems that hold promise for enhancing targeted cancer therapy. The research findings underscore the potential of these systems to improve treatment outcomes and patient quality of life.